Cambridge Healthtech Institute Announces Its Third Annual “Next Generation DX Summit” Moving Assays to the Clinic

Share Article

The Summit will showcase improvements in technology research and development with an emphasis towards application to the clinical laboratory and commercialization.

Cambridge Healthtech Institute will host its third annual Next Generation Dx Summit from August 23-25, 2011 in Washington, DC. Building on last year's success, the Summit is designed to bring together all of the major players in the evolving areas of diagnostics. The seven meetings comprising the Summit will showcase improvements in technology research and development with an emphasis towards application to the clinical laboratory and commercialization.

The Plenary Keynote session this year will be two Panel discussions. The first is an armchair discussion on the Changing Regulation of LDTs, with Alberto Gutierrez from the Office of in vitro Diagnostic Device Evaluation and Safety at the FDA, moderated by Franklin R. Cockerill, III, from the Mayo Medical Laboratories and Mayo Collaborative Services. The second panel will be on the Future of Reimbursement for Molecular Diagnostics, moderated by Thomas Gustafson from Arnold & Porter LLP. Ann-Marie Lynch from Advanced Medical Technology Association (AdvaMed) and David Mongillo from the American Clinical Laboratory Association will be two of the panelists.

The three-day conference features over 90 speakers covering topics from Point-of-Care Diagnostics to Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease to Companion Diagnostics, and three new meetings on Translating Proteomics and Metabolomics into the Clinical Laboratory, Mass Spectrometry in Clinical Diagnostics, and Commercialization of Molecular Diagnostics. You will hear from speakers such as: Daniel Wattendorf (DARPA), Kent Lewandrowski (Harvard Medical School), Daniel Chan (Johns Hopkins), Gregory Storch (St. Louis Children's Hospital), Stafford O'Kelly (Abbott Molecular), Richard Ding (bioMerieux), and Peter Collins (GSK).

Additionally, there are seven pre-conference short courses on Monday, August 22nd and two dinner short courses on Wednesday, August 24th. These are dynamic, information-rich sessions. A wide range of topics for the scientist and clinician are offered. Please visit the event website for more details.

There are plenty of other highlights as well, including breakout discussion groups, which offer the opportunity to discuss relevant topics in small group settings. This year's Exhibit Hall will feature an expanding number of exhibit booths and extensive poster presentations.

For more information on the Next Generation Dx Summit, please visit the event website at

About Cambridge Healthtech Institute (CHI)
Cambridge Healthtech Institute (CHI) (, founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Contact: Kaushik Chaudhuri
Cambridge Healthtech Institute
(781) 972-5419


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tracey Fielding
Cambridge Healthtech Institute
(781) 972-5429
Email >
Visit website